These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20334983)

  • 1. The "soft collagen" hypothesis in the pathogenesis of the inflammatory bowel disease and the seronegative spondylarthritides.
    Vounotrypidis P; Kouklakis G
    Med Hypotheses; 2010 Sep; 75(3):284-6. PubMed ID: 20334983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances and perspectives in the genetics of inflammatory bowel diseases.
    Chamaillard M; Iacob R; Desreumaux P; Colombel JF
    Clin Gastroenterol Hepatol; 2006 Feb; 4(2):143-51. PubMed ID: 16469672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: Inflammatory bowel disease and genetics.
    Weersma RK; van Dullemen HM; van der Steege G; Nolte IM; Kleibeuker JH; Dijkstra G
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():57-65. PubMed ID: 18081650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inflammatory bowel disease: IBD].
    Endo K; Shiga H; Kinouchi Y; Shimosegawa T
    Rinsho Byori; 2009 Jun; 57(6):527-32. PubMed ID: 19621784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Etiology and pathogenesis of spondyloarthritides].
    Anić B; Cerovec M
    Reumatizam; 2011; 58(2):36-8. PubMed ID: 22232944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The genetic basis of inflammatory bowel disease unravelled by genetic association studies].
    Visschedijk MC; Festen EA; Wijmenga C; Weersma RK
    Ned Tijdschr Geneeskd; 2009; 153():A402. PubMed ID: 19900309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of inflammatory bowel disease: progress and prospects.
    Mathew CG; Lewis CM
    Hum Mol Genet; 2004 Apr; 13 Spec No 1():R161-8. PubMed ID: 14764625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inflammatory bowel diseases: an immunological approach].
    Sepúlveda SE; Beltrán CJ; Peralta A; Rivas P; Rojas N; Figueroa C; Quera R; Hermoso MA
    Rev Med Chil; 2008 Mar; 136(3):367-75. PubMed ID: 18575665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells from spondylarthritis-prone HLA-B27-transgenic rats display altered cytoskeletal dynamics, class II major histocompatibility complex expression, and viability.
    Dhaenens M; Fert I; Glatigny S; Haerinck S; Poulain C; Donnadieu E; Hacquard-Bouder C; André C; Elewaut D; Deforce D; Breban M
    Arthritis Rheum; 2009 Sep; 60(9):2622-32. PubMed ID: 19714626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathogenesis of inflammatory bowel disease: current concepts.
    Bamias G; Cominelli F
    Curr Opin Gastroenterol; 2007 Jul; 23(4):365-9. PubMed ID: 17545770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-B27 transgenic rat: an animal model mimicking gut and joint involvement in human spondyloarthritides.
    Milia AF; Ibba-Manneschi L; Manetti M; Benelli G; Messerini L; Matucci-Cerinic M
    Ann N Y Acad Sci; 2009 Sep; 1173():570-4. PubMed ID: 19758201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunological and genetic basis of inflammatory bowel disease.
    Bouma G; Strober W
    Nat Rev Immunol; 2003 Jul; 3(7):521-33. PubMed ID: 12876555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the molecular dissection of inflammatory bowel disease.
    Siminovitch KA
    Semin Immunol; 2006 Aug; 18(4):244-53. PubMed ID: 16679026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical aspects of inflammatory bowel disease.
    Siegmund B; Zeitz M
    Eur J Immunol; 2009 Aug; 39(8):2026-30. PubMed ID: 19672897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of NOD2 variants in spondylarthritis.
    Crane AM; Bradbury L; van Heel DA; McGovern DP; Brophy S; Rubin L; Siminovitch KA; Wordsworth BP; Calin A; Brown MA
    Arthritis Rheum; 2002 Jun; 46(6):1629-33. PubMed ID: 12115195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant role of genetics in IBD: the NOD2 gene.
    Cho JH
    Rev Gastroenterol Disord; 2003; 3 Suppl 1():S18-22. PubMed ID: 12684585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology, genes and inflammatory bowel diseases in childhood.
    de Mesquita MB; Civitelli F; Levine A
    Dig Liver Dis; 2008 Jan; 40(1):3-11. PubMed ID: 17997369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel development in extraintestinal manifestations and spondylarthropathy.
    De Vos M; Hindryckx P; Laukens D
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25 Suppl 1():S19-26. PubMed ID: 21640926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of gut microbiota in mediating the effect of NOD2 defects in inflammatory bowel disease.
    Rogler G
    Gut; 2010 Feb; 59(2):153-4. PubMed ID: 20176638
    [No Abstract]   [Full Text] [Related]  

  • 20. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis.
    Agius LM
    J Theor Biol; 2004 Mar; 227(2):219-28. PubMed ID: 14990386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.